1/14/2014 9:55:09 AM
SAN FRANCISCO--(BUSINESS WIRE)--Carmot Therapeutics announced today that it has entered into a collaboration and license agreement with Amgen, Inc. (Thousand Oaks, CA). During the collaboration Carmot will apply its proprietary Chemotype Evolution to discover novel drug leads for two targets selected by Amgen. Carmot and Amgen will work together to identify and optimize drug candidates, while Amgen will be solely responsible for their clinical development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by